Year: 2022

Chest CT Lesion Size in Acute COVID-19 Can Predict Late Myocardial Injury

Chest CT Lesion Size in Acute COVID-19 Can Predict Late Myocardial Injury NOTE :The study covered in this summary was published in medRxiv.org as a preprint and has not yet been peer reviewed. KEY POINTS: 1:Left ventricular (LV) and right ventricular (RV) global longitudinal strain (GLS) were reduced in patients with severe pulmonary lesions (at […]

COVID-19 Study Updates

FDA Approved New Med for Lennox – Gastaut Syndrome

Gastaut Syndrome – FDA Approved New Med for Lennox The US Food and Drug Administration (FDA) has approved fenfluramine (Fintepla) oral solution, a Schedule IV controlled substance, for the treatment of seizures associated with Lennox-Gastaut syndrome (LGS) in children aged 2 years and older, the company has announced. Fenfluramine is already approved in the US […]

New Drug Approvals